Publications by authors named "Dalia D Hadi"
Article Synopsis
- Heart failure with preserved ejection fraction (HFpEF) is common, representing 40%-50% of new heart failure cases, but effective treatment options are still uncertain, with SGLT2 inhibitors emerging as a potential solution.
- The study analyzed data from 8 randomized controlled trials involving over 16,500 participants, concluding that SGLT2 inhibitors like empagliflozin and dapagliflozin reduce the risk of cardiovascular hospitalizations without significantly affecting overall mortality rates.
- The findings suggest that SGLT2 inhibitors are safe and beneficial for HFpEF patients, regardless of factors like kidney function or comorbid conditions.
Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension.
Dalia D Hadi Mohammed Dheyaa Marsool Marsool Ali Dheyaa Marsool Marsool Neel Vora Sajjad G Al-Badri Khadija A Hamza
Immun Inflamm Dis
November 2023
Article Synopsis
- Idiopathic pulmonary fibrosis (IPF) is a serious lung disease with no cure, causing irreversible lung scarring due to unknown genetic and environmental factors, and current treatments aim to slow progression and manage symptoms.
- Recent research explored new treatment options, including Saracatinib, which shows potential to be more effective than existing FDA-approved drugs for IPF, Pirfenidone and Nintedanib, and Sotatercept, which may help with pulmonary hypertension associated with the disease.
- This review highlights the potential for these advancements to improve IPF patient quality of life, but emphasizes the need for further studies to confirm their safety and efficacy.
Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus.
Priyadarshi Prajjwal Mohammed Dheyaa Marsool Marsool Pugazhendi Inban Bhavya Sharma Shahnaz Asharaf Dalia Dhia Hadi
Dis Mon
May 2023
Dementia is a chronic progressive cognitive decline illness that results in functional impairment. Vascular dementia (VaD), second only to Alzheimer's disease (AD), is one of the most prevalent forms of dementia in the elderly (aged over 65 years), with a varied presentation and unpredictable disease development caused by cerebrovascular or cardiovascular illness. To get a better understanding of the changes occurring in the brain and to drive therapy efforts, new biomarkers for early and precise diagnosis of AD and VaD are required.
View Article and Find Full Text PDF